Erasca (ERAS) Interest Expenses (2020 - 2026)
Erasca (ERAS) posted Interest Expenses of $672.8 million for Q1 2026, up 44752.4% on a QoQ basis from $1.5 million in Q4 2025, and up 44752.4% year-over-year from N/an in Q1 2025.
Erasca (ERAS) Interest Expenses (2020 - 2026) Analysis & Trends
Erasca's Interest Expenses history runs 7 years deep, the most recent figure standing at $672.8 million for Q1 2026.
- Quarterly Interest Expenses rose 44752.4% year-over-year to $672.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $672.8 million (up 10423.79% YoY) and the FY2025 annual result came in at $242.2 million, up 1764.65% from the prior year.
- Interest Expenses was $672.8 million for Q1 2026 at Erasca, up from $1.5 million in the prior quarter.
- Across five years, Interest Expenses topped out at $672.8 million in Q1 2026 and bottomed at $993000.0 in Q4 2022.
- A 5-year average of $65.9 million and a median of $16.7 million in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses plunged 86.98% — and 2026, when it jumped 44752.4%.
- Erasca's Interest Expenses stood at $993000.0 in 2022, then surged by 121.55% to $2.2 million in 2023, then declined by 22.73% to $1.7 million in 2024, then fell by 11.76% to $1.5 million in 2025, then soared by 44752.4% to $672.8 million in 2026.
- Business Quant data shows ERAS's Interest Expenses at $672.8 million in Q1 2026, $1.5 million in Q4 2025, and $16.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 672.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 672.79 Mn |
| Mar 31, 2026 | 672.79 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 16.53 Mn |
| Sep 30, 2025 | 16.53 Mn |
| Jun 30, 2025 | 17.62 Mn |
| Jun 30, 2025 | 17.62 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 16.66 Mn |
| Sep 30, 2024 | 16.66 Mn |
| Jun 30, 2024 | 76.19 Mn |
| Jun 30, 2024 | 76.19 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Dec 31, 2023 | 2.20 Mn |